Recombinant Human Anti-HBV Antibody (C9G9)
This product is a human monoclonal IgG kappa antibody targeting human hepatitis B surface antigen. Antibody C9G9 can effectively block the HBV replication in vitro, and therefore has a good ability to neutralize the hepatitis B virus, as prevention of HBV infection drugs.
Supplier | Creative Biolabs |
---|---|
Product # | HPAB-0002-WJ |
Pricing | Inquiry |
Host | Human |
Target | HBV |
Species Reactivity | Hepatitis B virus |
Type | Human IgG |
Applications | Neut |